Search Contract Opportunities

Development Of a Concentrated Tranexamic Acid (TXA) Intramuscular Injection   11

ID: 75A50125C00018 • Type: Award Notice • Match:  95%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:

Description

This award is for the development of a concentrated Tranexamic Acid (TXA) Intramuscular Injection. The Government seeks this development in order to receive FDA approval for the concentrated IM TXA formulation that can be delivered in a pref-filled syringe or a dedicated autoinjector.

This contract action was awarded competitively as a Cost Share Contract. A Cost Share Contract was used in accordance with FAR 35.006 (c) due to an absence of precise specifications and difficulties in estimating costs with accuracy.

Show All

Overview

Awardee
Rafa Laboratories
Award ID
75A50125C00018
Reported Award
$186,004,780
Agency
HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) [HHS]
Award Date
Sept. 30, 2025
Posted
Oct. 1, 2025, 12:30 p.m. EDT
Set Aside
None
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN13 - Health R&D Services; Health Care Services; Experimental Development
Place of Performance
Jerusalem, IL-JM Israel
Source
Open
Current SBA Size Standard
1000 Employees
Pricing
Multiple Types Common
Development Of a Concentrated Tranexamic Acid (TXA) Intramuscular Injection (75A50125C00018) was awarded to Rafa Laboratories on 10/1/25 by HHS Office of the Assistant Secretary for Preparedness and Response.
Primary Contact
Name
Erin Greninger, Contracting Officer   Profile
Email
erin.greninger@hhs.gov
Phone
None

Documents

Posted documents for Award Notice 75A50125C00018

Opportunity Assistant

AI Analysis

Opportunity Lifecycle

Procurement notices related to Award Notice 75A50125C00018

Award Notifications

Agency published notification of awards for Award Notice 75A50125C00018

Similar Active Opportunities

Open contract opportunities similar to Award Notice 75A50125C00018

Experts for Development Of a Concentrated Tranexamic Acid (TXA) Intramuscular Injection

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE > BARDA - ASPR / DAAPPO / BARDA DCMA
FPDS Organization Code
7505-00100
Source Organization Code
100188027
Last Updated
Oct. 1, 2025
Last Updated By
erin.greninger@hhs.gov
Archive Date
Oct. 15, 2025